Effect of endocrine therapy on growth of T61 human breast cancer xenografts is directly correlated to a specific down-regulation of insulin-like growth factor II (IGF-II)
- 31 December 1993
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 29 (4), 562-569
- https://doi.org/10.1016/s0959-8049(05)80152-2
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Blockade of the type I somatomedin receptor inhibits growth of human breast cancer cells in athymic mice.JCI Insight, 1989
- Demonstration of insulin-like growth factor (IGF-I and -II) receptors and binding protein in human breast cancer cell linesBiochemical and Biophysical Research Communications, 1988
- An antibody to the receptor for insulin-like growth factor I inhibits the growth of MCF-7 cells in tissue cultureBiochemical and Biophysical Research Communications, 1987
- Evidence that transforming growth factor-β is a hormonally regulated negative growth factor in human breast cancer cellsCell, 1987
- Serum steroid levels in intact and endocrine ablated BALB/C nude mice and their intact littermatesThe Journal of Steroid Biochemistry and Molecular Biology, 1986
- Effect of tamoxifen on the receptor-positive T61 and the receptor-negative T60 human breast carcinomas grown in nude miceEuropean Journal of Cancer and Clinical Oncology, 1985
- Characterization of the T61 human breast carcinoma established in nude miceEuropean Journal of Cancer and Clinical Oncology, 1985
- Sequence of a cDNA clone encoding human preproinsulin-like growth factor IINature, 1984
- Randomized Clinical Trial of Diethylstilbestrol versus Tamoxifen in Postmenopausal Women with Advanced Breast CancerNew England Journal of Medicine, 1981
- Isolation of biologically active ribonucleic acid from sources enriched in ribonucleaseBiochemistry, 1979